ALERT: Presidential Executive Order Aims to Accelerate Psychedelics Access & Research

President Trump signed an executive order on April 18, 2026, aiming to accelerate access to psychedelics, provide federal funding for state-backed research, and enhance collaboration between public and industry bodies. This directive indicates a significant federal push for the psychedelics sector, potentially paving the way for streamlined regulatory pathways and expanded market opportunities. Merchants should closely monitor the evolving landscape for both compliance considerations and growth prospects stemming from this executive action.

President Trump's executive order, signed on April 18, 2026, aims to significantly impact the psychedelics industry by accelerating access, providing funding for state-backed research, and enhancing collaboration between public bodies and industry partners. This marks a pivotal moment for the sector.

Sentinel Insight